Analysts See $0.09 EPS for Shake Shack Inc. (SHAK) on May, 3

Analysts have a consensus recommendation of 2.80 based on a 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell. The firm has "Sell" rating given on Thursday, February 15 by Jefferies. Currently, 43.1% of the company's shares are sold short. Rehmann Capital Advisory Group bought a new stake in shares of Shake Shack in the 4th quarter valued at approximately $273,000. Shake Shack has a 12-month low of $30.12 and a 12-month high of $47.39. The stock has a market cap of $1,597.68, a price-to-earnings ratio of 76.21, a PEG ratio of 4.22 and a beta of 1.28.

Shake Shack (NYSE:SHAK) last posted its quarterly earnings data on Thursday, February 15th. The company reported $0.09 EPS for the quarter, hitting the Thomson Reuters' consensus estimate of $0.09. The business had revenue of $96.14 million during the quarter, compared to analyst estimates of $92.80 million. Shake Shack had a positive return on equity of 9.47% and a negative net margin of 0.63%. The average 1-year target price among analysts that have issued a report on the stock in the last year is $40.81. Its shares touched $43.95 on during the last trading session after 1.17% change.Currently Shake Shack uptrending after 27.12% change in last April 16, 2017.

Several equities analysts have recently issued reports on the company. The firm earned "Equal-Weight" rating on Thursday, November 2 by Barclays Capital. Barclays decreased their price target on Shake Shack from $49.00 to $45.00 and set an "equal weight" rating for the company in a report on Friday, February 16th. On Thursday, December 7 the stock of Shake Shack Inc. The stock has an average rating of "Hold" and an average target price of $38.69. Suntrust Robinson upgraded Shake Shack Inc. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. The SI to Shake Shack Inc Class A's float is 35.7%. The shares were sold at an average price of $31.96, for a total value of $63,920.00. The institutional investor owned 508,593 shares of the company's stock after selling 106,007 shares during the quarter. The disclosure for this sale can be found here. The ratio dived, as 118 funds opened new or increased holdings, while 167 trimmed and sold positions in Mallinckrodt PLC. On Thursday, November 2 the stock has "Underweight" rating by Morgan Stanley. Zevenbergen Capital Investments LLC bought a new stake in Shake Shack during the third quarter worth about $24,073,000.

Mallinckrodt public limited company develops, makes, markets, and distributes branded and generic specialty pharmaceutical products and therapies in the United States, Europe, the Middle East, Africa, and internationally. Neuberger Berman Group LLC now owns 24,194 shares of the company's stock worth $839,000 after buying an additional 4,244 shares during the period. Finally, Gilder Gagnon Howe & Co. Gilder Gagnon Howe & Co. Municipal Employees Retirement System of MI now owns 6,960 shares of the company's stock worth $231,000 after acquiring an additional 2,580 shares during the period. With 715,500 avg volume, 10 days are for Shake Shack Inc Class A (NYSE:SHAK)'s short sellers to cover SHAK's short positions. Shacks offers hamburgers, hot dogs, crispy chicken, crinkle-cut fries, shakes, frozen custard, beer, shakes, wine, and other it has negative earnings. The Company's signature items are its all-natural, hormone and antibiotic-free burgers, hot dogs, crispy chicken, crinkle cut fries, shakes and frozen custard. On Friday, February 16 SunTrust maintained the shares of SHAK in report with "Buy" rating.



Latest news

Trump Blasts China, Russia for Devaluing Currencies as Fed Hikes
I don't know why he's tying United States interest rates into that but ok. "This is unacceptable!" - trump wrote on Twitter.

Xact Kapitalforvaltning AB Has $5 Million Stake in Yum! Brands (YUM)
Following the transaction, the chief executive officer now directly owns 10,160 shares of the company's stock, valued at $862,584. The stock has a market capitalization of $28,403.27, a price-to-earnings ratio of 29.14, a PEG ratio of 2.05 and a beta of 0.84.

Analysts Issued Domtar Corp (UFS) Target Price at $40.40
In 2017Q4 Securities and Exchange filling is reported Qv Investors Inc's stake in Domtar Corp (UFS) which was reduced by 22.6%. A company that manages their assets well will have a high return, while if manages their assets poorly will have a low return.

Anticipated $5.08 EPS for Regeneron Pharmaceuticals, Inc. (REGN) on May, 3
Stratos Wealth Partners Limited holds 0% of its capital in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) for 4,365 shares. Solaris Asset Lc, a New York-based fund reported 125 shares. 248,001 were accumulated by Ameriprise Inc. (NASDAQ:PCLN).

London’s Medical Startups Challenge Welcomes a New Judge, Max Polyakov
MBios is a joint project of Innovation House and the Ukrainian Medical Association of the United Kingdom (UMAUK). Such kind of challenges provides the participants with an opportunity to present their projects to the world.

Other news